Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
43 hedge funds and large institutions have $58.1M invested in Genocea Biosciences, Inc. in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
5% more funds holding
Funds holding: 41 → 43 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
51% less capital invested
Capital invested by funds: $118M → $58.1M (-$60M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$972K |
| 2 |
AM
Ares Management
Los Angeles,
California
|
+$431K |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$423K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$342K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$313K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$1.01M |
| 2 |
OC
Oppenheimer & Co
New York
|
-$376K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$222K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$207K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$108K |
GNCA Hedge Fund Activity: Q3 2014 in Review
43 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q3 2014, worth a combined $58.1M — down 51% from $118M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GNCA positions and 5 closed out — a net gain of 2 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Deerfield Management, adding an estimated $972K. The largest seller was Polaris Venture Management Co V, cutting an estimated $1.01M.
- 43 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q3 2014, up from 41 in Q2 2014.
- Funds reported $58.1M of Genocea Biosciences, Inc. stock for Q3 2014, down 51% quarter-over-quarter.
- 7 funds opened new Genocea Biosciences, Inc. positions in Q3 2014 and 5 closed out, a net change of +2 holders.
- The largest Genocea Biosciences, Inc. buyer in Q3 2014 was Deerfield Management, an estimated $972K added.
- The largest Genocea Biosciences, Inc. seller in Q3 2014 was Polaris Venture Management Co V, an estimated $1.01M sold.
Based on aggregated 13F filings for Q3 2014.